Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E C Cole

Showing results (151-160 of 160) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 160 results.
Journal of Nephrology|May 17, 2014
Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor geneGiuseppe Vezzoli, Alfredo Scillitani, Sabrina Corbetta, et al.
American Journal of Medical Genetics. Part A|February 9, 2012
Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome)Miles D Thompson, Tony Roscioli, Carlo Marcelis, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2006
Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptorAlfredo Scillitani, Vito Guarnieri, Claudia Battista, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2005
Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemiaKarl P Schlingmann, Martin C Sassen, Stefanie Weber, et al.
Endocrine|May 8, 2016
Vitamin D status in primary hyperparathyroidism: effect of genetic backgroundClaudia Battista, Vito Guarnieri, Vincenzo Carnevale, et al.
European Journal of Endocrinology|December 25, 2010
Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidismGiuseppe Vezzoli, Alfredo Scillitani, Sabrina Corbetta, et al.
Plos One|December 17, 2013
Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 geneValerio Pazienza, Annamaria la Torre, Filomena Baorda, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2014
Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohortsLeonardo D'Agruma, Michela Coco, Vito Guarnieri, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 19, 2012
CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohortVito Guarnieri, Claudia Battista, Lucia Anna Muscarella, et al.
Nature|September 19, 2014
Ancient human genomes suggest three ancestral populations for present-day EuropeansIosif Lazaridis, Nick Patterson, Alissa Mittnik, et al.
Pageof 16

Showing results (151-160 of 160) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 160 results.
Journal of Nephrology|May 17, 2014
Risk of nephrolithiasis in primary hyperparathyroidism is associated with two polymorphisms of the calcium-sensing receptor geneGiuseppe Vezzoli, Alfredo Scillitani, Sabrina Corbetta, et al.
American Journal of Medical Genetics. Part A|February 9, 2012
Phenotypic variability in hyperphosphatasia with seizures and neurologic deficit (Mabry syndrome)Miles D Thompson, Tony Roscioli, Carlo Marcelis, et al.
The Journal of Clinical Endocrinology and Metabolism|October 5, 2006
Primary hyperparathyroidism and the presence of kidney stones are associated with different haplotypes of the calcium-sensing receptorAlfredo Scillitani, Vito Guarnieri, Claudia Battista, et al.
Journal of the American Society of Nephrology : JASN|August 19, 2005
Novel TRPM6 mutations in 21 families with primary hypomagnesemia and secondary hypocalcemiaKarl P Schlingmann, Martin C Sassen, Stefanie Weber, et al.
Endocrine|May 8, 2016
Vitamin D status in primary hyperparathyroidism: effect of genetic backgroundClaudia Battista, Vito Guarnieri, Vincenzo Carnevale, et al.
European Journal of Endocrinology|December 25, 2010
Polymorphisms at the regulatory regions of the CASR gene influence stone risk in primary hyperparathyroidismGiuseppe Vezzoli, Alfredo Scillitani, Sabrina Corbetta, et al.
Plos One|December 17, 2013
Identification and functional characterization of three NoLS (nucleolar localisation signals) mutations of the CDC73 geneValerio Pazienza, Annamaria la Torre, Filomena Baorda, et al.
The Journal of Clinical Endocrinology and Metabolism|October 4, 2014
Increased prevalence of the GCM2 polymorphism, Y282D, in primary hyperparathyroidism: analysis of three Italian cohortsLeonardo D'Agruma, Michela Coco, Vito Guarnieri, et al.
Cellular Oncology (Dordrecht, Netherlands)|September 19, 2012
CDC73 mutations and parafibromin immunohistochemistry in parathyroid tumors: clinical correlations in a single-centre patient cohortVito Guarnieri, Claudia Battista, Lucia Anna Muscarella, et al.
Nature|September 19, 2014
Ancient human genomes suggest three ancestral populations for present-day EuropeansIosif Lazaridis, Nick Patterson, Alissa Mittnik, et al.
Pageof 16